Vanacker, Hélène http://orcid.org/0000-0001-9934-5719
Treilleux, Isabelle
Schiffler, Camille
Bieche, Ivan
Campone, Mario
Patsouris, Anne http://orcid.org/0000-0001-9101-5424
Arnedos, Monica
Cottu, Paul H. http://orcid.org/0000-0001-6434-3932
Jacquin, Jean-Philippe
Dalenc, Florence
Pinton, Antoine
Servant, Nicolas
Attignon, Valéry
Rouleau, Etienne
Morel, Alain
Legrand, François
Jimenez, Marta http://orcid.org/0000-0002-4233-8478
Andre, Fabrice http://orcid.org/0000-0001-5795-8357
Bachelot, Thomas http://orcid.org/0000-0002-0866-9484
Article History
Received: 7 June 2023
Revised: 27 November 2023
Accepted: 11 December 2023
First Online: 5 January 2024
Competing interests
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Mario Campone reports consulting or advisory role with Astra ZENECA, Novartis, Sanofi, Lilly, Pfizer, Gilead, Daiichi-Sankyo, consulting with Pierre Fabre Oncology, Sanofi, Novartis, Servier, Daiichi-Sankyo, PET- Therapy, Diaccurate, travel accomodation with Pfizer, Novartis, Roche, Astra Zeneca Anne Patsouris reports travel accommodation by Roche, Pfizer, ESAI, Lilly, MUNDIPHARMA. Monica Arnedos reports honoraria with Novartis, Pfizer, Gilead, Astra Zeneca, Roche, Astra Zeneca, Daiichi Sankyo and Pfizer (to institution), and travel accomodation with Novartis, Daiichi Sankyo, Pfizer, Lilly, Astra Zeneca. Paul H. Cottu reports consulting role with Pfizer, Roche, Lilly, Pierre Fabre, Novartis, NanoString Technologies, Seagen. Florence Dalenc reports consulting role with DAICHI, AZ, PFIZER, NOVARTIS, SEAGEN and travel/congress support with DAICHI, PFIZER, NOVARTIS, GILEAD. Etienne Rouleau reports consulting role with AstraZeneca, BMS, Roche,Clovis, MSDGSK and Research funding from AstraZeneca. Alain Morel, reports consulting role and research funding with Astrazeneca, GSK, MSD. Fabrice Andre reports stock and Other Ownership Interest with PEGASCY and institutionnal research fundings from AstraZeneca, Novartis, Pfizer, Lilly, Roche, Daiichi, and travel accommodations, from Novartis, Roche, GlaxoSmithKline, AstraZeneca. Thomas Bachelot reports consulting role and institutional research funding from Seagen, Pfizer, AstraZeneca/Daiichi, Novartis, Lilly, and non-financial support from Pfizer, all outside the submitted work. Hélène Vanacker, Isabelle Treilleux, Camille Schiffler,Ivan Bieche, Jean-Philippe Jacquin, Antoine Pinton, Nicolas Servant, valery Attignon, François Legrand, Marta Jimenez declare no conflict of interest.
: This study was approved by an independent Ethics Committee (Comité De Protection des Personnes Sud-Est II-2014 -036 B). All patients provided written informed consent.
: Not applicable in absence of any individual person’s data.